Emergency Neurological Life Support Intracerebral Hemorrhage

Similar documents
Emerging therapies for Intracerebral Hemorrhage

High Risk Emergency Medicine

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Critical Bleeding Reversal Protocol

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery

LAMC Reversal Agent Guideline for Anticoagulants Time to resolution of hemostasis (hrs) Therapeutic Options

Blood products and pharmaceutical emergencies

Guidelines and Protocols

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center


3/3/2015. Patrick Cobb, MD, FACP March 2015

48 th Annual Meeting. Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding. Terminology. Disclosure. Public Health Impact.

Acute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)

EMMC Guide on Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults. February, 2013

The management of cerebral hemorrhagic complications during anticoagulant therapy

New Anticoagulants: What to Use What to Avoid

Xabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center

Disclosure. Outline. Objectives. I have no actual or potential conflict of interest in relation to this presentation.

DVT/PE Management with Rivaroxaban (Xarelto)

Disclosures. Objective (NRHS) Self Assessment #2

The Brave New (Anticoagulant) World

The author has no disclosures

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

Clinical Guideline N/A. November 2013

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia

The Clinical Evaluation of the Comatose Patient in the Emergency Department

How does warfarin work? We know itʼs a vitamin k antagonist, but what does that mean? What's really getting antagonized?

Anticoagulation and Reversal

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

9/5/14. Objectives. Atrial Fibrillation (AF)

STARTING, SWITCHING OR STOPPING NEW ORAL ANTICOAGULANTS: A Practical Approach

Update on Antiplatelets and anticoagulants. Outlines. Antiplatelets and Anticoagulants 1/23/2013. Timir Paul, MD, PhD

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012

Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults

5/21/2012. Perioperative Use Issues. On admission: During hospitalization:

East Kent Prescribing Group

Anticoagulant reversal for intracranial hemorrhage (ICH) and other life threatening bleeding- update 2013 *

Reversal of Anticoagulants at UCDMC

What to do in case of hemorragia. L Camoin Jau Service d Hématologie APHM Marseille

Cardiology Update 2014

10/16/2013. Reversal of Anticoagulants: Something New Under the Sun? Disclosures. Pharmacist Objectives

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

Program Objectives. Why Use Anticoagulants? 6/5/2014

Speaker Disclosure. Outline. Pharmacist Objectives. Patient Case. Outline 9/4/2014

Appendix C Factors to consider when choosing between anticoagulant options and FAQs

Warfarin and Novel Anti-Coagulants: Management Before and After the Cath Lab

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

MANAGING BLEEDING IN THE

QUICK REFERENCE. Mary Cushman 1 Wendy Lim 2 Neil A Zakai 1. University of Vermont 2. McMaster University

Dabigatran (Pradaxa) Guidelines

Optimizing Anticoagulation Selection for Your Patient. C. Andrew Brian MD, FACC NCVH 2015

Making Sense of the Newer Anticoagulants

Impact of new (direct) oral anticoagulants in patient blood management

Oral anticoagulants new and old: bleeding risk and management strategies. Logan Tinsen Pharm.D. Benefis Hospitals

Anticoagulant Reversal

AR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.

Approved: Acute Stroke Ready Hospital Advanced Certification Program

Using the Pupillometer in Clinical Practice

Level III Stroke Center Data Collection Requirements

EMS Management of Stroke. Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D.

Managing Anticoagulation for Atrial Fibrillation 2015

The New Anticoagulants are Here! Do you know how to use them? Arrhythmia Winter School February 11 th, Jeff Healey

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care

Time of Offset of Action The Trial

Pulmonary Embolism Treatment Update

CONTEMPORARY REVERSAL OF ANTICOAGULATION

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).

Anticoagulants in Atrial Fibrillation

. 2015;46: DOI: /STR )

Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D.

Anticoagulation Therapy Update

The speakers have attested that their presentation will be free of all commercial bias toward a specific company and its products.

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Committee Approval Date: September 12, 2014 Next Review Date: September 2015

New Oral Anticoagulants. How safe are they outside the trials?

Traveller s Thrombosis. Dr. Peter Verhamme Vascular Medicine and Haemostasis UZ Leuven

NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS

Management of the anticoagulated patient who presents with intracranial haemorrhage Rebecca Appelboam, Exeter, UK

Management of Antithrombotics with Procedures. Jordan Weinstein, MD

New Anticoagulants for the Treatment of Thromboembolism With a little subplot on superficial thrombophlebitis. Mark Crowther

Review of Newer Antiplatelets, Antithrombotics and Reversal

Head Injury. Dr Sally McCarthy Medical Director ECI

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness SOGH April

Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient

Dr Gordon Royle Haematologist, Middlemore Hospital

NOACS AND AF PEARLS AND PITFALLS DR LAURA YOUNG HAEMATOLOGIST

THE NEW GENERATION OF ORAL ANTICOAGULANTS

Comparison between New Oral Anticoagulants and Warfarin

UPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK

New in Atrial Fibrillation

Traditional anticoagulants

New anticoagulants: Monitoring or not Monitoring? Not Monitoring

Anticoagulation Essentials! Parenteral and Oral!

1/12/2016. What s in a name? What s in a name? NO.Anti-Coagulation. DOACs in clinical practice. Practical aspects of using

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Dr Gordon Royle Haematologist, Middlemore Hospital

Transcription:

Emergency Neurological Life Support Intracerebral Hemorrhage Version: 2.0 Last Updated: 19-Mar-2016 Checklist & Communication

ICH Table of Contents Emergency Neurological Life Support... 1 Intracerebral Hemorrhage... 1 Checklist... 3 Communication... 3 Disposition: ICU, Surgery or Transfer... 4 ICU admission... 4 Airway... 5 Is the patient's airway stable?... 5 Anticoagulants and DIC... 6 INR > 1.4... 6 Antiplatelet Agents... 8 Aspirin, clopidogrel, prasugrel, etc.... 8 Blood Pressure... 9 Should BP be lowered?... 9 Hemorrhage Location...10 Brain location of ICH...10 Coagulopathy...11 Is there an underlying coagulopathy?...11 Control BP...12 Continue to control blood pressure...12 Heparin...13 Recent heparin administration...13 ICH Score...14 Calculate the ICH score...14 ICH Volume...15 Measure the hematoma volume...15 ICP Elevated...16 Is the patient at risk for high ICP?...16 Intracerebral Hemorrhage (ICH) Diagnosis...17 ICH diagnosis confirmed...17 Other findings...18 CT spot sign...18 Primary Intervention...19 First steps for intervention...19 Secondary Treatment...20 Begin secondary interventions...20 Seizures...21 Seizure management...21 Surgery...22 Is the patient a surgical candidate?...22

ICH Page 3 Checklist Check PT, PTT, INR Obtain head imaging results Measure hematoma volume Calculate GCS Calculate ICH Score Communication Age ICH volume and location GCS ICH Score Presence of hydrocephalus Blood pressure Coagulation parameters and anticoagulant reversal treatments given Plan for surgery

ICH Page 4 Disposition: ICU, Surgery or Transfer ICU admission NeuroICU admission is preferable. If a NeuroICU bed is not available, then general ICU admission is preferred. The key is to have frequent neuro checks in patients who may suffer a decline in neurological and/or airway status so interventions can occur quickly. If the patient is not ventilated and not on IV antihypertensive agents, then a step-down unit is an alternative as long as frequent neuro checks can be obtained. If the patient is a surgical candidate, then direct transfer to the OR may be an option. If ICU services are not available or surgery is not available, consider emergent transfer to an institution with these services. Critical care transportation may be necessary depending on airway status, hemorrhage location and size, and judgment about the risk of neurological worsening in transport.

ICH Page 5 Airway Is the patient's airway stable? ICH may continue to expand and the patient's mental status and airway may become compromised. Continued airway assessment is critical especially in posterior fossa hemorrhages. Therefore, frequent neuro checks are important in this early phase of ICH to identify and intervene in a patient who is declining. See ENLS protocol Airway, Ventilation and Sedation for discussion on how to intubate.

ICH Page 6 Anticoagulants and DIC INR > 1.4 See the ENLS reference Pharmacotherapy for a detailed listing of medications and dosing for reversal of anticoagulant drugs. Consider vitamin K antagonist reversal with purified factor concentrates or FFP if patient has taken warfarin or other vitamin K antagonists, followed by vitamin K 10 mg IV. 4-factor prothrombin complex concentrates (PCC) are preferred to FFP. To calculate the volume of plasma or IU of prothrombin complex concentrate: 1. Decide on target INR 2. Convert INR to percent (%) functional prothrombin complex: INR Range Percent function prothrombin complex > 5 5% 4.0-4.9 10% 2.6-3.9 15% 2.2-2.5 20% 1.9-2.1 25% 1.7-1.8 30% 1.4-1.6 40% 1.0 100% 3. Calculate dose: (Target in %PC - Current level in %PC) X weight (kg) = ml of FFP or IU of PCC needed Example: a patient with INR on arrival = 7.5, target INR 1.5, body weight = 80 kg: (40-5) X 80 = 2,800 Therefore, the needed dose is 2,800 ml of FFP or 2,800 IU of PCC. Reference: Schulman, S. Care of patients receiving long-term anticoagulant therapy. NEJM (2003) 349:675 For patients with ICH and having taken dabigatran, idarucizumab may be used to reverse the anticoagulant effects of dabigatran. The recommended dose of idarucizumab is 5 g, provided as two separate vials each containing 2.5 g/50 ml idarucizumab. If idarucizumab is not available consider rviia 80μg/kg.

ICH Page 7 While no specific reversal agents exist for direct Xa inhibitors, one could consider activated charcoal if the last dose was within 8 hours. Consider PCC 30 IU/kg for rivaroxaban or apixaban. FFP and vitamin K are not effective.

ICH Page 8 Antiplatelet Agents Aspirin, clopidogrel, prasugrel, etc. If the patient has been taking antiplatelet drugs, it is reasonable to transfuse with platelets and consider administering DDAVP 0.3 mcg/kg IV however there is little evidence basis for this practice.

ICH Page 9 Blood Pressure Should BP be lowered? Keep SBP below 140 mm Hg; consider using IV nicardipine with or without IV labetalol. See ENLS reference Pharmacotherapy for details on IV antihypertensive dosing.

ICH Page 10 Hemorrhage Location Brain location of ICH Determine where the hemorrhage is located (may be more than single site). Options include: lobar basal ganglia thalamus cerebellum midbrain pons intraventricular

ICH Page 11 Coagulopathy Is there an underlying coagulopathy? If yes, consider presence of oral or parenteral anticoagulants, antiplatelet agents, liver failure and DIC.

ICH Page 12 Control BP Continue to control blood pressure Keep SBP below 140 mm Hg; consider immediate treatment with IV labetolol and using IV nicardipine infusion to maintain control. See ENLS reference Pharmacotherapy for details on IV antihypertensive dosing.

ICH Page 13 Heparin Recent heparin administration Administer protamine sulfate IV 1 mg per 100 U heparin received in last 2 hours; maximum dose 50 mg IV. See ENLS reference Pharmacotherapy for details on IV anticoagulant reversal dosing.

ICH Page 14 The ICH score can be calculated as follows: ICH Score Calculate the ICH score Component Criteria Points CGS 3-4 2 5-12 1 13-15 0 ICH Volume 30 ml 1 < 30 ml 0 Intraventricular hemorrhage Yes 1 No 0 Infratentorial origin Yes 1 No 0 Age 80 years 1 < 80 years 0 Total 0-6 The ICH score is a method to determine severity of illness. Although it is correlated with mortality, one should not use any particular score to limit care.

ICH Page 15 ICH Volume Measure the hematoma volume If the blood is within the brain parenchyma, use the ABC/2 method. ABC/2 method for estimating ICH hematoma volume. Right basal ganglia intracerebral hemorrhage. The axial CT image with the largest cross sectional area of hemorrhage is selected. In this example, the largest diameter A is 6 cm, the largest diameter perpendicular to A on the same image B is 3 cm, and hemorrhage is seen on 6 slices of 0.5 cm (5 mm) thickness for a C of 3 cm (not shown). Thus, the hematoma volume is (6 X 3 X 3)/2 = 27 cc. Note that for C, if the hematoma area on a slice is approximately 25-75 % of the hematoma area on the reference slice used to determine A, then this slice is considered half a hemorrhage slice, and if the area is <25 % of the reference slice, the slice is not considered a hemorrhage slice.

ICH Page 16 ICP Elevated Is the patient at risk for high ICP? Consider ICP monitoring if GCS < 8 or the patient has symptomatic hydrocephalus. See ENLS protocol Elevated ICP and Herniation for management recommendations.

ICH Page 17 Intracerebral Hemorrhage (ICH) Diagnosis ICH diagnosis confirmed Intracerebral Hemorrhage (ICH): ICH typically produces a sudden, new headache followed by progressive neurological signs. The onset is usually sudden and many patient s neurological symptoms progress over a few hours likely due to continued intracerebral bleeding. It is not possible to be certain whether the stroke is due to hemorrhage or ischemia based on signs and symptoms alone, so some form of emergent brain imaging is necessary. Topic Co-Chairs: Edward Jauch, MD MS Jose A Pineda, MD J. Claude Hemphill, MD, MAS

ICH Page 18 Other findings CT spot sign If IV contrast was administered during the CT scan, extravasation of contrast within the hematoma may suggest active bleeding. This is called the spot sign as shown in the figure:

ICH Page 19 Primary Intervention First steps for intervention Intervention for ICH is classified as "primary" meaning what can be done to impact the patient right now, and "secondary" once these primary interventions are addressed. One should consider the secondary interventions of blood pressure control, declining neurological exam requiring airway protection, concurrently.

ICH Page 20 Secondary Treatment Begin secondary interventions Secondary interventions are critical in the ongoing care of the ICH patient, especially in consideration of transfer of the patient from the Emergency Department to the intensive care unit or to a hospital with a higher level of care.

ICH Page 21 Seizures Seizure management Do not administer anticonvulsants prophylactically. Treat clinical seizures with benzodiazepines then anticonvulsants. Consider EEG monitoring if the patient's level of consciousness is less than is likely explained by the size and location of the hemorrhage.

ICH Page 22 Surgery Is the patient a surgical candidate? Cerebellar ICH should be considered for surgery urgently depending on size. Typically, surgery is considered for hematomas in excess of 3 cm in any dimension, and neurosurgery should be consulted urgently for any patient with cerebellar ICH and hydrocephalus. Consider surgery for lobar ICH with mass effect in severely affected but salvageable patients and as a life-saving measure in patients who are herniating.